These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30472772)

  • 1. Hepatitis C: Is eradication possible?
    Lombardi A; Mondelli MU;
    Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of pediatric hepatitis C.
    El-Shabrawi MH; Kamal NM
    World J Gastroenterol; 2013 Nov; 19(44):7880-8. PubMed ID: 24307782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C eradication: A long way to go.
    Waheed Y
    World J Gastroenterol; 2015 Nov; 21(43):12510-2. PubMed ID: 26604658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.
    Ansaldi F; Orsi A; Sticchi L; Bruzzone B; Icardi G
    World J Gastroenterol; 2014 Aug; 20(29):9633-52. PubMed ID: 25110404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.
    Vespasiani-Gentilucci U; Galati G; Gallo P; De Vincentis A; Riva E; Picardi A
    World J Gastroenterol; 2015 Jun; 21(24):7412-26. PubMed ID: 26139987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of vaccines for hepatitis C virus infection.
    Ghasemi F; Rostami S; Meshkat Z
    World J Gastroenterol; 2015 Nov; 21(42):11984-2002. PubMed ID: 26576087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment as prevention and cure towards global eradication of hepatitis C virus.
    Hagan LM; Wolpe PR; Schinazi RF
    Trends Microbiol; 2013 Dec; 21(12):625-33. PubMed ID: 24238778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.
    Scott N; Wilson DP; Thompson AJ; Barnes E; El-Sayed M; Benzaken AS; Drummer HE; Hellard ME
    BMC Med; 2019 Sep; 17(1):175. PubMed ID: 31530275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral Hepatitis C: From Unraveling the Nature of Disease to Cure and Global Elimination.
    Basyte-Bacevice V; Kupcinskas L
    Dig Dis; 2024; 42(5):486-495. PubMed ID: 38718765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best strategies for global HCV eradication.
    Hagan LM; Schinazi RF
    Liver Int; 2013 Feb; 33 Suppl 1(0 1):68-79. PubMed ID: 23286849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is global elimination of HCV realistic?
    Calvaruso V; Petta S; Craxì A
    Liver Int; 2018 Feb; 38 Suppl 1():40-46. PubMed ID: 29427499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal model for hepatitis C virus infection].
    Tsukiyama-Kohara K; Kohara M
    Uirusu; 2015; 65(2):255-262. PubMed ID: 27760924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Therapies for Hepatitis C Virus.
    Polenakovik H
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):119-32. PubMed ID: 27442378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will there be an HCV meeting in 2020? Summary of the 17th international meeting on hepatitis C virus and related viruses.
    Wakita T; Suzuki T; Evans MJ; Shimotohno K; Chayama K; Matsuura Y; Hijikata M; Moriishi K; Seya T; Enomoto N; Koike K; Kato N; Kanto T; Hotta H
    Gastroenterology; 2011 Jul; 141(1):e1-5. PubMed ID: 21620847
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C Virus Diagnosis and the Holy Grail.
    Applegate TL; Fajardo E; Sacks JA
    Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.